ES2120059T3 - Preparado para estimular el riego sanguineo conteniendo particulas fuertemente magneticas. - Google Patents

Preparado para estimular el riego sanguineo conteniendo particulas fuertemente magneticas.

Info

Publication number
ES2120059T3
ES2120059T3 ES94922222T ES94922222T ES2120059T3 ES 2120059 T3 ES2120059 T3 ES 2120059T3 ES 94922222 T ES94922222 T ES 94922222T ES 94922222 T ES94922222 T ES 94922222T ES 2120059 T3 ES2120059 T3 ES 2120059T3
Authority
ES
Spain
Prior art keywords
dispersion
prepared
magnetic particles
strong magnetic
hexaferrite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94922222T
Other languages
English (en)
Inventor
Leonhard Zastrow
Dagmar Hulsenberg
Karin Golz
Klaus Stanzl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lancaster Group AG
Original Assignee
Lancaster Group AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lancaster Group AG filed Critical Lancaster Group AG
Application granted granted Critical
Publication of ES2120059T3 publication Critical patent/ES2120059T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
    • A61N1/406—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia using implantable thermoseeds or injected particles for localized hyperthermia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212—Face masks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/47—Magnetic materials; Paramagnetic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/12—Face or body powders for grooming, adorning or absorbing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Abstract

LA INVENCION SE REFIERE A UNA PREPARACION PARA LA MEJORA DE SUMINISTRO DE SANGRE. EL PROBLEMA CON LAS PREPARACIONES ANTERIORES CONOCIDAS O PROCESOS RESIDE EN EL HECHO DE QUE LOS COMPONENTES MAGNETICOS SUAVES A SER INTRODUCIDOS EN EL CUERPO EN CAPSULAS, A PARTIR DE UN CAMPO MAGNETICO, TENIAN QUE SER APLICADOS DESPUES DE LA APLICACION DE PARTICULAS DESMAGNETIZADAS EN LA PIEL. EL PROPOSITO DE LA INVENCION ES SUMINISTRAR UNA NUEVA PREPARACION PARA MEJORAR EL SUMINISTRO DE SANGRE EN DONDE SE UTILIZAN PARTICULAS MAGNETICAS ENDURECIDAS ESPECIALES. DE ACUERDO CON LA INVENCION LA PREPARACION PARA LA MEJORA DEL SUMINISTRO DE SANGRE CONSISTE EN UN MEDIO ACEPTABLE FARMACEUTICAMENTE O COSMETICAMENTE Y POSIBLEMENTE OTROS ADITIVOS, CONTENIENDO PARTICULAS DE GRADO INDIVIDUAL MAGNETICAS ENDURECIDAS, FINAMENTE DISTRIBUIDAS CON UNA ALTA INTENSIDAD DE CAMPO COERCITIVA Y TAMAÑOS DE GRANO EN EL CAMPO DESDE 600 HASTA 1.200 NM. LAS DISPERSIONES DE ESTA PREPARACION NO EXHIBEN AGREGACION DE LAS PARTICULAS MAGNETICASENDURECIDAS. LA UTILIZACION PREFERENTE SE ENCUENTRA EN EL CAMPO COSMETICOS Y DERMATOLOGICO.
ES94922222T 1993-07-19 1994-07-19 Preparado para estimular el riego sanguineo conteniendo particulas fuertemente magneticas. Expired - Lifetime ES2120059T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4325071A DE4325071C2 (de) 1993-07-19 1993-07-19 Präparat zur Durchblutungsförderung

Publications (1)

Publication Number Publication Date
ES2120059T3 true ES2120059T3 (es) 1998-10-16

Family

ID=6493751

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94922222T Expired - Lifetime ES2120059T3 (es) 1993-07-19 1994-07-19 Preparado para estimular el riego sanguineo conteniendo particulas fuertemente magneticas.

Country Status (20)

Country Link
US (2) US5800835A (es)
EP (1) EP0710113B1 (es)
JP (1) JP3955090B2 (es)
KR (1) KR100334120B1 (es)
AT (1) ATE167059T1 (es)
AU (1) AU7344294A (es)
BR (1) BR9406299A (es)
CA (1) CA2157393C (es)
CZ (1) CZ284269B6 (es)
DE (2) DE4325071C2 (es)
DK (1) DK0710113T3 (es)
ES (1) ES2120059T3 (es)
GR (1) GR3027779T3 (es)
HU (1) HU220373B (es)
IL (1) IL110314A (es)
NZ (1) NZ269795A (es)
PL (1) PL175132B1 (es)
SK (1) SK279930B6 (es)
WO (1) WO1995003061A1 (es)
ZA (1) ZA945230B (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT237100Y1 (it) * 1995-08-01 2000-08-31 Mamphis S A S Di Vanna Brambil Preparati cosmetici magnetizzati
US6306384B1 (en) * 1996-10-01 2001-10-23 E-L Management Corp. Skin battery cosmetic composition
DE19715478A1 (de) * 1997-04-10 1998-10-15 Lancaster Group Gmbh Kosmetisches und dermatologisches Mittel auf Basis von hartmagnetischen Teilchen
DE19715477B4 (de) * 1997-04-10 2006-05-11 Lancaster Group Gmbh Verfahren und Vorrichtung zur Herstellung hartmagnetischer Einbereichsteilchen mit hoher Koerzitivfeldstärke
DE19734547B4 (de) 1997-08-01 2004-08-19 Lancaster Group Gmbh Kosmetische Zusammensetzungen mit agglomerierten Substraten
US6170711B1 (en) 1998-02-18 2001-01-09 E-L Management Corp. Package containing dispensing device with magnet
US6761896B1 (en) 1998-10-29 2004-07-13 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Skin cosmetic care system and method
FR2791570B1 (fr) * 1999-03-31 2003-04-04 Oreal Patch a effet de champ magnetique
US6503761B1 (en) * 1999-10-19 2003-01-07 Kimberly-Clark Worldwide, Inc. Selective removal of contaminants from a surface using articles having magnets
US6841393B2 (en) 1999-10-19 2005-01-11 Kimberly-Clark Worldwide, Inc. Selective removal of contaminants from a surface using colored particles and articles having magnets
FR2804870B1 (fr) * 2000-02-16 2002-08-16 Oreal Structure composite a matrice adhesive contenant un ou plusieurs actifs
FR2805720B1 (fr) 2000-03-03 2002-08-16 Oreal Dispositif comprenant un applicateur et/ou un organe d'essorage magnetique
JP3542319B2 (ja) * 2000-07-07 2004-07-14 昭栄化学工業株式会社 単結晶フェライト微粉末
CA2382142C (fr) 2000-07-12 2005-08-23 L'oreal Dispositif de conditionnement et/ou d'application contenant des fibres comportant au moins un corps aimante ou aimantable
FR2825247B1 (fr) 2001-06-05 2004-04-23 Oreal Dispositif de conditionnement et/ou d'application contenant des fibres comportant au moins un corps aimante ou aimantable
US6733797B1 (en) 2000-11-15 2004-05-11 William K. Summers Neuroceutical for improving memory and cognitive abilities
WO2002053114A1 (en) * 2001-01-03 2002-07-11 Giovanni Cosmetics, Inc. Magnetic body care compositions
DE10106288A1 (de) * 2001-02-02 2002-09-05 Coty Bv Revitalisierender Wirkkomplex für die Haut
FR2822711B1 (fr) * 2001-03-28 2003-06-13 Oreal Dispositif de traitement comportant une enveloppe definissant une cavite dans laquelle peut-etre engagee une partie du corps
US20030022203A1 (en) * 2001-04-23 2003-01-30 Rajan Kumar Cellular Arrays
FR2825246B1 (fr) * 2001-06-05 2004-06-04 Oreal Dispositif de conditionnement et/ou d'application comprenant des fibres comportant des particules capables d'absorber un liquide ou un compose en solution dans ce liquide ou de se dissoudre dans un liquide
US7670623B2 (en) 2002-05-31 2010-03-02 Materials Modification, Inc. Hemostatic composition
WO2004000244A1 (en) * 2002-06-24 2003-12-31 Dead Sea Laboratories Ltd. Cosmetic compositions comprising small magnetic particles
US7560160B2 (en) * 2002-11-25 2009-07-14 Materials Modification, Inc. Multifunctional particulate material, fluid, and composition
DE10257240B4 (de) * 2002-12-04 2005-03-10 Coty Bv Kosmetische Zusammensetzung mit elektrischen Ladungsträgern und deren Verwendung
US7200956B1 (en) 2003-07-23 2007-04-10 Materials Modification, Inc. Magnetic fluid cushioning device for a footwear or shoe
DE10336841A1 (de) * 2003-08-11 2005-03-17 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetische Zusammensetzung zur Unterstützung des Sauerstofftransports in die Haut
DE10342449A1 (de) * 2003-09-13 2005-04-07 Beiersdorf Ag Verwendung von Sauerstoff in kosmetischen oder dermatologischen Zubereitungen
EP1694284B1 (de) * 2003-09-30 2008-12-10 Coty B.V. Kosmetisches und dermatologisches mittel mit magnetteilchen, dessen herstellung und verwendung
US7448389B1 (en) 2003-10-10 2008-11-11 Materials Modification, Inc. Method and kit for inducing hypoxia in tumors through the use of a magnetic fluid
JP2007509938A (ja) * 2003-10-31 2007-04-19 カラー アクセス，インコーポレイティド 電磁場抑制組成物
US20050118124A1 (en) * 2003-12-01 2005-06-02 Reinhart Gale M. Compositions for treating keratinous surfaces
DE102004001267A1 (de) * 2004-01-07 2005-08-18 Beiersdorf Ag Verwendung von Sauerstoffträgern zur Förderung des Haarwuchses
KR101159392B1 (ko) 2005-05-04 2012-06-28 코티 프레스티지 랭카스터 그룹 게엠베하 화학요법에 의해 야기되는 피부 및 모발의 손상을 예방또는 치료하기 위한 용도를 지닌 유리-라디칼 스캐빈저
US20070183998A1 (en) * 2005-12-28 2007-08-09 L'oreal Cosmetic composition
DE102006041365B4 (de) * 2006-08-28 2010-09-02 Peter Gleim Vorrichtung zur Erzeugung eines pulsierenden elektromagnetischen Feldes mit Impulssteuerung
JP2009051752A (ja) * 2007-08-24 2009-03-12 Hitachi Ltd 磁性粒子含有薬剤キャリア及びそれを用いた治療装置
ITMI20072098A1 (it) * 2007-10-30 2009-04-30 Dermophisiologique S R L Una composizione cosmetica a base di un materiale magnetico o magnetizzabile, la sua preparazione ed il suo uso per la pulizia dell'epidermide
DE102008008473A1 (de) 2008-02-07 2009-08-13 Coty Prestige Lancaster Group Gmbh Hauttönungsmittel mit DHA auf Basis Wasser-Wachs-Öl
DE102008053889B4 (de) * 2008-10-30 2014-06-12 Lts Lohmann Therapie-Systeme Ag Steuerbares therapeutisches System

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335094A (en) * 1979-01-26 1982-06-15 Mosbach Klaus H Magnetic polymer particles
US4364377A (en) * 1979-02-02 1982-12-21 Walker Scientific, Inc. Magnetic field hemostasis
US4345588A (en) * 1979-04-23 1982-08-24 Northwestern University Method of delivering a therapeutic agent to a target capillary bed
US4331654A (en) * 1980-06-13 1982-05-25 Eli Lilly And Company Magnetically-localizable, biodegradable lipid microspheres
FR2508802A1 (fr) * 1981-07-03 1983-01-07 Thomson Csf Procede d'hyperthermie medicale utilisant une poudre magnetique par voie sanguine, et dispositif de mise en oeuvre de ce procede
EP0093757A1 (en) * 1981-11-12 1983-11-16 Ulf SCHRÖDER Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof
US4454234A (en) * 1981-12-30 1984-06-12 Czerlinski George H Coated magnetizable microparticles, reversible suspensions thereof, and processes relating thereto
US4452773A (en) * 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
WO1984002031A1 (en) * 1982-11-10 1984-05-24 Sintef Magnetic polymer particles and process for the preparation thereof
JPS59116214A (ja) * 1982-12-24 1984-07-05 Magune Kk 医療用磁気プラスタ−
JPS59139314A (ja) * 1983-01-31 1984-08-10 Inoue Japax Res Inc 歯みがき剤
US4554088A (en) * 1983-05-12 1985-11-19 Advanced Magnetics Inc. Magnetic particles for use in separations
US4590922A (en) * 1983-08-19 1986-05-27 Gordon Robert T Use of ferromagnetic, paramagnetic and diamagnetic particles in the treatment of infectious diseases
PT81498B (pt) * 1984-11-23 1987-12-30 Schering Ag Processo para a preparacao de composicoes para diagnostico contendo particulas magneticas
WO1986003136A1 (en) * 1984-11-28 1986-06-05 University Patents, Inc. Affinity chromatography using dried calcium alginate-magnetite separation media in a magnetically stabilized fluidized bed
DE3502998A1 (de) * 1985-01-30 1986-07-31 Detlef Dr. 5100 Aachen Müller-Schulte Mittel zur selektiven tumortherapie sowie verfahren zur herstellung und verwendung derselben
US4654165A (en) * 1985-04-16 1987-03-31 Micro Tracers, Inc. Microingredient containing tracer
US4758429A (en) * 1985-11-04 1988-07-19 Gordon Robert T Method for the treatment of arthritis and inflammatory joint diseases
JPS62197425A (ja) * 1986-02-25 1987-09-01 Toyo Soda Mfg Co Ltd 球状熱可塑性樹脂の製造方法
US4813399A (en) * 1986-07-18 1989-03-21 Gordon Robert T Process for the treatment of neurological or neuromuscular diseases and development
US4814098A (en) * 1986-09-06 1989-03-21 Bellex Corporation Magnetic material-physiologically active substance conjugate
US4714711A (en) * 1986-11-05 1987-12-22 Merck & Co., Inc. 6-hydroxy-2(2-hydroxy-4-methoxyphenyl)benzofuran derivatives to inhibit leukotriene biosynthesis
WO1988005337A1 (en) * 1987-01-16 1988-07-28 Clarkson University Process for preparation of monodispersed barium containing ferrites
DE3824359A1 (de) * 1988-04-07 1989-10-19 Bayer Ag Verbundmembranen, verfahren zu ihrer herstellung und ihre verwendung
ES2066851T3 (es) * 1988-05-24 1995-03-16 Anagen Uk Ltd Particulas atraibles magneticamente y metodo de preparacion.
GB8813144D0 (en) * 1988-06-03 1988-07-06 Nycomed As Compositions
WO1990007322A1 (en) * 1988-12-19 1990-07-12 David Gordon Diagnosis and treatment of viral effects
JPH04108710A (ja) * 1990-08-27 1992-04-09 Yoko Shiga 磁性化粧料
DE4221255C2 (de) * 1992-06-26 1994-09-15 Lancaster Group Ag Phospholipide enthaltendes Kosmetikum
US5411730A (en) * 1993-07-20 1995-05-02 Research Corporation Technologies, Inc. Magnetic microparticles

Also Published As

Publication number Publication date
CA2157393A1 (en) 1995-02-02
DK0710113T3 (da) 1999-03-22
US5919490A (en) 1999-07-06
CA2157393C (en) 1999-03-23
IL110314A0 (en) 1994-10-21
DE4325071A1 (de) 1995-01-26
BR9406299A (pt) 1995-12-26
GR3027779T3 (en) 1998-11-30
DE4325071C2 (de) 1995-08-10
JP3955090B2 (ja) 2007-08-08
JPH09500141A (ja) 1997-01-07
AU7344294A (en) 1995-02-20
HU220373B (hu) 2002-01-28
IL110314A (en) 1998-06-15
ATE167059T1 (de) 1998-06-15
EP0710113A1 (de) 1996-05-08
KR100334120B1 (ko) 2002-09-27
WO1995003061A1 (de) 1995-02-02
PL310982A1 (en) 1996-01-22
DE59406230D1 (de) 1998-07-16
CZ284269B6 (cs) 1998-10-14
PL175132B1 (pl) 1998-11-30
EP0710113B1 (de) 1998-06-10
SK279930B6 (sk) 1999-05-07
CZ261995A3 (en) 1996-02-14
HUT73321A (en) 1996-07-29
NZ269795A (en) 1997-03-24
US5800835A (en) 1998-09-01
KR960700735A (ko) 1996-02-24
HU9503809D0 (en) 1996-02-28
ZA945230B (en) 1995-02-27
SK129795A3 (en) 1996-06-05

Similar Documents

Publication Publication Date Title
ES2120059T3 (es) Preparado para estimular el riego sanguineo conteniendo particulas fuertemente magneticas.
NZ337796A (en) Cosmetic and dermatological agent with a hard-magnetic particle base specifically treating sensitive tissue and fatty tissue, for treatment of wounds and hair
GEP20032957B (en) Nonpeptidyl Compositions
DE69120430D1 (de) Mittel zur verstaerkung der wirkung von antitumoralen mittel und zur widerstandsbekaempfung von vielfachdrogen
DE3883035D1 (de) Saponinkomplexe mit phospholipiden und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
DE69723092D1 (de) Zubereitungen aus immunogenen molekülen, die granulozyten-makrophagen-stimulierenden faktor als adjuvans enthalten
CA2148795A1 (en) Compositions of oak bark extract, related synthetic compositions, and method of using same
ZA948669B (en) New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions
ATE232394T1 (de) Verwendung von modifiziertem c-reaktiven protein zur herstellung eines medikaments zur behandlung von krebs
GR3022321T3 (en) Use of il-4 to treat solid tumors
DE50310916D1 (de) Kosmetisches und dermatologisches mittel mit magnetteilchen, dessen herstellung und verwendung
HK1003137A1 (en) New pyrazine derivatives their preparation and their use
DE69311541T2 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
ES2127469T3 (es) Composiciones dermatologicas que contienen una sal del acido lactico.
DE59207280D1 (de) Verfahren zur Herstellung von stabilen, hydrophilen oder ambiphilen Creme-Zubereitungen, enthaltend vesikuläre Bestandteile, und deren Verwendung
EP0170269A3 (en) Medicated cosmetic compositions
ATE173608T1 (de) Präparat gegen haarausfall und brüchiche nägel
DE3613280A1 (de) Koerperpackung, vorzugsweise gesichtsmaske fuer kosmetische und/oder therapeutische zwecke
EP0348664A3 (en) Pharmaceutical compositions containing monoacetoacetins for treating tumours
ES2118831T3 (es) Preparaciones que contienen carboplatino o lobaplatino para la terapia antitumoral y/o para la estimulacion del sistema hemotopoyetico.
Katz et al. Current status of antiviral substances
Libal et al. Performance of Finishing Pigs as Affected by Prior Performance and the Addition of an Antibiotic during the Finishing Period
SU1832499A3 (ru) Вещество, проявляющее антигипоксическое и антигипотермическое свойства
Crookes On Metallic Colloids and Their Bactericidal Properties
TH24107A (th) แม่เหล็กที่ถูกทำให้แม่เหล็กอย่างต่อเนื่อง

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 710113

Country of ref document: ES